# US 2013/0240377 A1 · Voltammetric Systems for Assaying Biological Analytes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0240377 A1
- Document ID: US20130240377A1
- Status: Published application
- Kind: A1
- Application number: 13/611,557
- Filed: 2012-09-12
- Published: 2013-09-19
- Earliest claimed: 2004-05-15
- Assignees: Bayer Healthcare LLC - Diabetes Care
- Inventors: Huan-Ping Wu
- Web page: https://patentgrep.com/patent/US20130240377A1

## CPC

- G01N 27/3272: {Test elements therefor, i.e. disposable laminated substrates with electrodes, reagent and channels (optical biosensors G01N33/52)}
- C12Q 1/005: {involving specific analytes or enzymes (including groups of enzymes, e.g. oxydases; C12Q1/004 takes precedence)}
- G01N 27/327: Biochemical electrodes {, e.g. electrical or mechanical details for in vitro measurements}
- G01N 27/3273: {Devices therefor, e.g. test element readers, circuitry (details not specific to biochemical electrodes G01N33/4875)}
- G01N 27/48: using polarography, i.e. measuring changes in current under a slowly-varying voltage
- G01N 27/49: Systems involving the determination of the current at a single specific value, or small range of values, of applied voltage for producing selective measurement of one or more particular ionic species
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The present invention relates to systems, methods, and devices for determining the concentration of an analyte in a sample. The use of linear, cyclic, or acyclic voltammetric scans and/or semi-integral, derivative, or semi-derivative data treatment may provide for increased accuracy when determining the concentration of an analyte in a sample. Hematocrit compensation in combination with the data treatments may reduce the hematocrit effect with regard to a glucose analysis in whole blood. In another aspect, fast scan rates may reduce the hematocrit effect.

## Claims

### Claim 1

A method of determining the concentration of an analyte in a sample, comprising:
applying a voltammetric forward linear scan to the sample,
where the forward linear scan applies a changing voltage;
measuring current as a function of the changing voltage;
applying a data treatment to the measured current; and
determining a concentration of an analyte in the sample in response to the data treatment.

### Claim 2 (depends on 1)

The method of claim 1, where the analyte is selected from the group consisting of glucose, cholesterol, triglycerides, lactate, pyruvate, alcohol, bilirubin, uric acid, NAD(P)H, and carbon monoxide.

### Claim 3 (depends on 2)

The method of claim 2, where the sample is blood.

### Claim 4 (depends on 1)

The method of claim 1, further comprising applying a voltammetric reverse linear scan to the sample at a reversing point of the forward linear scan.

### Claim 5 (depends on 4)

The method of claim 4, where the voltammetric forward and reverse linear scans comprise an acyclic scan.

### Claim 6 (depends on 4)

The method of claim 4, where the voltammetric forward and reverse linear scans comprise a cyclic scan.

### Claim 7 (depends on 4)

The method of claim 4, where the reverse scan comprises at least 25 mV of steady-state region.

### Claim 8 (depends on 7)

The method of claim 7, where the steady-state region of the scan comprises a change in electrochemical current with respect to voltage of at most ±10%.

### Claim 9 (depends on 4)

The method of claim 4, where the reversing point is selected to provide from 25 to 400 mV of steady-state region.

### Claim 10 (depends on 1)

The method of claim 1, further comprising changing the voltage of the forward scan at a rate of at least 176 mV/second.

### Claim 11 (depends on 10)

The method of claim 10, further comprising changing the voltage of the forward scan at a rate of at least 500 mV/second.

### Claim 12 (depends on 1)

The method of claim 1, where the forward scan comprises a scan range from 400 to 1000 mV.

### Claim 13 (depends on 1)

The method of claim 1, where the forward scan comprises at least one voltage providing at least a 100:1 concentration ratio between two species of a redox pair.

### Claim 14 (depends on 1)

The method of claim 1, where the forward scan comprises at least one potential at a working electrode of at least 180 mV.

### Claim 15 (depends on 1)

The method of claim 1, where the data treatment is selected from the group consisting of a semi-integral data treatment, a derivative data treatment, a semi-derivative data treatment, and combinations thereof.

### Claim 16 (depends on 1)

The method of claim 1, where the data treatment comprises a semi-integral data treatment.

### Claim 17 (depends on 16)

The method of claim 16, where the applying the data treatment comprises semi-integrating the currents from the forward linear scan and determining a steady-state semi-integral current.

### Claim 18 (depends on 16)

The method of claim 16, where the semi-integral data treatment separates at least one steady-state current from at least one hematocrit-affected equilibrium current.

### Claim at position 19

19-26. (canceled)

### Claim 30

A measuring device, for determining the concentration of an analyte in a sample, comprising:
contacts; and
electronic circuitry in electrical communication with the contacts, the electronic circuitry comprising:
an electric charger and a processor in electrical communication,
the processor in electrical communication with a computer readable storage medium;
where the processor measures current from the contacts, and
the computer readable storage medium comprises computer readable software code, which when executed by the processor, determines the concentration of the analyte in the sample from the current measured from the contacts;
where the computer readable software code, when executed by the processor, causes the electric charger to apply a voltammetric scan through the contacts, and causes the processor to implement a data treatment to the measured current,
the data treatment selected from the group consisting of a semi-integral data treatment, a derivative data treatment, a semi-derivative data treatment, and combinations thereof.

### Claim at position 21

31-39. (canceled)

### Claim 40

A measuring device, for determining the concentration of an analyte in a sample, comprising:
contacts; and
electronic circuitry in electrical communication with the contacts;
the electronic circuitry comprising
an electric charger and a processor in electrical communication, the processor in electrical communication with a computer readable storage medium;
where the processor measures current from the contacts, and
the computer readable storage medium comprises computer readable software code, which when executed by the processor, causes the electric charger to apply a voltammetric forward linear scan through the contacts and determines the concentration of the analyte in the sample from the current measured from the contacts.

### Claim at position 23

41-51. (canceled)
